healthcare accessibility – The Milli Chronicle

Monday, January 5, 2026

Latest:

Maduro Faces U.S. Drug Charges in New York as Venezuela Adjusts to Power Shock
Russia Reassesses Global Strategy After Losing Venezuela Ally Amid U.S. Power Play
Iran’s Leadership Faces Mounting Pressure as Protests Intensify and U.S. Actions Abroad Raise Alarm
Switzerland Freezes Assets Linked to Venezuela’s Maduro as International Pressure Mounts
Bird Flu Outbreaks Raise Fresh Poultry and Public Health Concerns in Southern India

Factual Version of a Story

Novo Nordisk Expands Weight-Loss Treatment Options with US Launch of Wegovy Oral Pill

The launch of Wegovy in pill form marks a major step in widening access to obesity treatment in the United

US Government Launches Generous Model to Cut Medicaid Prescription Costs

The U.S. government’s newly launched “Generous Model” marks a pivotal step in reshaping Medicaid’s prescription drug pricing, aiming to make

Featured News World

NewsDesk Milli Chronicle November 6, 2025November 6, 2025 affordable healthcare, American health programs, diabetes care, drug pricing reform, Eli Lilly, GLP-1 medications, healthcare accessibility, injectable treatments, Medicaid access, Medicaid benefits, medical affordability, Medicare coverage, Medicare discounts, Novo Nordisk, obesity treatment, orforglipron, pharmaceutical innovation, prescription savings, public-private partnership, Trump health deal, TrumpRx program, U.S. drug market, U.S. healthcare reform, Wegovy, weight-loss drugs, weight-loss pills, Zepbound

U.S. Strikes Breakthrough Deal to Boost Access to Weight-Loss Drugs

A landmark public-private partnership aims to make life-changing obesity and diabetes treatments more affordable and accessible for millions across America.